The FDA rejected Verrica Pharmaceuticals' molluscum contagiosum drug, VP-102, which would have been the first approved treatment for the viral skin condition. The rejection came after the company's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback